Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumour, Residual”

768 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 768 results

Testing effectiveness (Phase 2)Looking for participantsNCT05286957
What this trial is testing

MRD-guided Adjuvant Tislelizumab and Chemotherapy in Resected Stage IIA-IIIB NSCLC

Who this might be right for
NSCLC
The First Affiliated Hospital of Zhengzhou University 60
Post-approval studies (Phase 4)Study completedNCT00199004
What this trial is testing

Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab

Who this might be right for
Adult Acute Lymphocytic Leukemia
Johann Wolfgang Goethe University Hospital 60
Testing effectiveness (Phase 2)Looking for participantsNCT04333706
What this trial is testing

A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)

Who this might be right for
BreastMetastaticTriple Negative+2 more
University of Southern California 65
Very early researchActive Not RecruitingNCT04674306
What this trial is testing

Adjuvant Therapy With an Alpha-lactalbumin Vaccine in Triple-Negative Breast Cancer

Who this might be right for
Pathologic Stage IIA-IIIC Triple-Negative Breast CancerTNBC - Triple-Negative Breast CancerResidual Disease
George T. Budd 35
Testing effectiveness (Phase 2)Looking for participantsNCT06088381
What this trial is testing

Selective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL)

Who this might be right for
Head and Neck CancerHead and Neck Squamous Cell CarcinomaOropharynx Cancer+2 more
University of Maryland, Baltimore 61
Large-scale testing (Phase 3)Ended earlyNCT00956072
What this trial is testing

Imatinib Mesylate With or Without Surgery in Treating Patients With Metastatic Gastrointestinal Stromal Tumor That is Responding to Imatinib Mesylate

Who this might be right for
Gastrointestinal Stromal Tumor
European Organisation for Research and Treatment of Cancer - EORTC 12
Not applicableUnknownNCT05254821
What this trial is testing

Cell-free Tumor DNA as Minimal Residual Disease in Hodgkin Lymphoma Patients

Who this might be right for
Hodgkin Lymphoma
Federico II University 130
Testing effectiveness (Phase 2)Study completedNCT00199030
What this trial is testing

Treatment of Relapsed T-cell Acute Lymphoblastic Leukemia or T-lymphoblastic Lymphoma With MabCampath

Who this might be right for
Adult Acute Lymphocytic Leukemia T-cellLymphoma, Lymphoblastic
Goethe University 8
Testing effectiveness (Phase 2)Study completedNCT01781728
What this trial is testing

Palliative Stereotactic Radiation for Pancreatic or Periampullary Adenocarcinoma

Who this might be right for
Pancreatic CancerPeriampullary Adenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 48
Testing effectiveness (Phase 2)Looking for participantsNCT03965234
What this trial is testing

Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases

Who this might be right for
Metastatic Bone SarcomaMetastatic Malignant Neoplasm in the LungMetastatic Soft Tissue Sarcoma+3 more
Roswell Park Cancer Institute 99
Early research (Phase 1)Study completedNCT04634435
What this trial is testing

Autologous Memory-like NK Cell Therapy With BHV-1100 and Low Dose IL-2 in Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Biohaven Pharmaceuticals, Inc. 7
Testing effectiveness (Phase 2)Looking for participantsNCT06189833
What this trial is testing

Phase 2 Study Applying MRD Techniques for Participants With Previously Untreated Multiple Myeloma Treated With D-VRd Prior To and After High-dose Therapy Followed by ASCT - TAURUS

Who this might be right for
Multiple Myeloma
Stichting European Myeloma Network 200
Large-scale testing (Phase 3)Study completedNCT00512993
What this trial is testing

Postoperative Use of Zoledronic Acid in Breast Cancer Patients After Neoadjuvant Chemotherapy

Who this might be right for
Breast Cancer
GBG Forschungs GmbH 654
Testing effectiveness (Phase 2)Ended earlyNCT03441464
What this trial is testing

Feasibility of the LUM Imaging System for Detection of Prostate Cancer

Who this might be right for
Prostate CancerNeoplasm, Residual
Lumicell, Inc. 9
Large-scale testing (Phase 3)Looking for participantsNCT05232916
What this trial is testing

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

Who this might be right for
Breast Cancer
Greenwich LifeSciences, Inc. 750
Testing effectiveness (Phase 2)Looking for participantsNCT06414148
What this trial is testing

MRD-Directed Consolidation With Epcor-only or Epcor-R2 Post Anti-CD19 CAR TCell Therapy for Large B-Cell Lymphoma

Who this might be right for
Relapsed/Refractory Large B-cell Lymphoma
Peter MacCallum Cancer Centre, Australia 40
Post-approval studies (Phase 4)WithdrawnNCT02415257
What this trial is testing

Gentamicin Treatment Prior to Schwannoma Surgery - No Residual Function

Who this might be right for
Vestibular Schwannoma
Lund University
Not applicableStudy completedNCT06436768
What this trial is testing

Efficacy and Safety of Sugammadex in Thoracoscopy Thymectomy for Chinese Adults With Myasthenia Gravis

Who this might be right for
Reversal of Neuromuscular Blockade
Beijing Tongren Hospital 62
Testing effectiveness (Phase 2)Looking for participantsNCT07136077
What this trial is testing

Trial of Fruquintinib and Tislelizumab in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy

Who this might be right for
Minimal Residual DiseaseAdjuvant ChemotherapyColorectal Cancer+3 more
M.D. Anderson Cancer Center 20
Post-approval studies (Phase 4)Looking for participantsNCT07315828
What this trial is testing

Accuracy of Indocyanine Green (ICG) Fluorescence Imaging in Giant Cell Tumor of Bone Surgery

Who this might be right for
Giant Cell Tumor of Bone
Shanghai Jiao Tong University Affiliated Sixth People's Hospital 40
Load More Results